Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Feb. 28, 2022

Condensed Financial Information Disclosure [Abstract]

Schedule of the company’s previously issued balance

	As of February 28, 2021
	As Previously Reported			Adjustments			Reclassifications			As Restated			Notes
Accrued expenses (including accrued interest)	$	1,288,107		$	-		$	3,668		$	1,291,775		[1]
Note payable		159,922			-			(3,668	)		156,255		[1]
Derivative warrant liability		-			1,366,375			-			1,366,375		[A]
Additional paid-in capital		446,126,640			(136,004	)		-			446,249,272		[B]
					258,636			-					[C]
Accumulated deficit	$	(465,883,499	)	$	(1,366,375	)	$	-		$	(467,372,506	)	[A]
					136,004			-					[B]
					(258,636	)		-					[C]

Schedule of the company’s previously issued statement of operations

	As of February 28, 2021
	As Previously Reported		Adjustments			Reclassifications			As Restated			Notes
Selling, general and administrative expense	$	1,318,602	$	258,636		$	-		$	1,577,238		[C]
Interest expense		1,293,409		(13,460	)		-			1,279,949		[B]
Gain on extinguishment of debt		866,887		(133,500	)		2,713,652			3,447,039		[2]
Gain on extinguishment of derivative warrant liability		-		13,611			-			13,611		[A]
Change in fair value of derivative warrant liability		-		(432,714	)		-			(432,714	)	[A]
Other income		2,720,652		-			(2,713,652	)		7,000		[2]
Net income	$	842,528	$	(797,780	)	$	-		$	44,748
Net income per share, basic and diluted	$	0.01							$	0.00

Schedule of the company’s previously issued statement of shareholder deficit

	Common Stock Shares			Common Stock Amount		Additional Paid-In Capital		Accumulated Deficit			Total Shareholders’ Deficit
Balance, February 29, 2020, as previously reported		56,400,874		$	5,639	$	443,417,452	$	(466,726,027	)	$	(23,302,937	)
Prior period revisions		192,641			19		130,977		(691,227	)		(560,231	)
Corrections of errors		(4,469	)									-
Balance, February 29, 2020, as restated		56,589,046		$	5,658	$	443,548,428	$	(467,417,254	)	$	(23,863,168	)
Balance, February 28, 2021, as previously reported		71,107,442		$	7,109	$	446,126,640	$	(465,883,499	)	$	(19,749,750	)
Prior period revisions		-			-		122,632		(1,489,007	)		(1,366,375	)
Corrections of errors		(4,433	)									-
Balance, February 28, 2021, as restated		71,103,009		$	7,109	$	446,249,272	$	(467,372,506	)	$	(21,116,125	)

Schedule of the company’s previously issued statement of cash flows

	As of February 28, 2021
	As Previously Reported			Adjustments			Reclassifications			As Restated			Notes
Cash flows from operating activities:
Net income	$	842,528		$	(797,780	)	$	-		$	44,748		[A] [B] [C]
Gain on extinguishment of liabilities		(3,585,639	)		133,500			5,100			(3,447,039	)	[B]
Gain on debt settlement								(71,775	)		(71,775	)
Gain on extinguishment of derivative warrant liability		-			(13,611	)		-			(13,611	)	[A]
Change in fair value of derivative warrant liability		-			432,714			-			432,714		[A]
Share-based compensation expense		193,750			258,636			-			452,386		[C]
Changes in working capital assets and liabilities:
Operating lease right-to-use asset		-			-			7,220			7,220
Accounts payable and accrued expenses		99,839			-			(185,308	)		(85,469	)	[1]
Accrued interest on notes payable		847,987			(13,460	)		251,983			1,086,510		[B] [1]
Operating lease liability		(10,564	)		-			(7,220	)		(17,784	)
Supplemental schedule of non-cash transactions:
Notes payable converted into shares of common stock	$	267,000		$	(267,000	)	$	-		$	-		[B]